G LNK
AI-powered SaaS platform that automates the full Healthcare Professional (HCP) engagement lifecycle for pharma and life sciences companies — from AI-driven expert identification and KOL matching to compliant compensation management.
G LNK
AI-powered SaaS platform that automates the full Healthcare Professional (HCP) engagement lifecycle for pharma and life sciences companies — from AI-driven expert identification and KOL matching to compliant compensation management.
Executive Summary
G LNK is a YC W25 pre-seed company (founded 2024, $500K raised) building an AI-native platform to automate how pharma companies identify, engage, and compliantly pay healthcare professionals — a workflow that today costs the industry billions annually and is served by entrenched incumbents like Veeva and IQVIA. The core market thesis is legitimate: HCP engagement automation is a real, growing, and underserved niche, and the founding team has credible domain and technical credentials. However, with no independently verifiable revenue, customers, or enterprise pilots disclosed, traction is essentially zero at this stage, and the company is severely undercapitalized ($500K) for a compliance-heavy enterprise SaaS play with 12–24 month pharma sales cycles. The single biggest risk is regulatory: automating pharma-to-HCP compensation in the crosshairs of the Anti-Kickback Statute and Sunshine Act without a named compliance officer or healthcare legal expert on the team is a live liability that could sink the company before it reaches scale.
Run your own diligence
Upload a pitch deck or paste any company URL to get a full AI-powered due diligence report in under 2 minutes.
Get started free →Free plan available · No credit card required